News

A new study has shown that platinum-based chemotherapy drugs, used to treat some colorectal cancers, can accumulate in surrounding healthy cells and reduce the tumor's sensitivity to treatment.

A promising targeted drug has been identified that could be effective against rare, hard-to-treat leukemias.

New research has linked the genetic changes that occur in kidney cancer to patient outcomes, and could be used to better predict the risk of the disease coming back.

Mistletoe extract has been widely used to support cancer therapy and improve quality of life, but there has been a lack of clinical trials and data to support its use until a recent trial from Johns Hopkins Kimmel Cancer Center.

A new study has characterized “fingerprints” in calcium mineral deposits (microcalcifications), revealing pathological clues to the progression of breast cancer and potentially other diseases.

During the fetal stage, a number of cell programs run that are vital to the development of the fetus. Researchers from Lund University have demonstrated that one of these fetal programs appears to protect against leukemia.

A new study has highlighted the benefits of whole genome sequencing of classic Hodgkin lymphoma over exome sequencing.

A 53-year-old male patient in Düsseldorf is the third person to achieve long-term human immunodeficiency virus type 1 (HIV-1) remission after receiving a stem cell therapy. The case study is published in Nature.

According to research, the loss of a single copy of CDKNA/B genes can significantly accelerate the recurrence of aggressive meningiomas.

A new study has identified three substances that can fight tumour growth and reduce liver metastases.